Key Takeaways
- • CVC Capital Partners to acquire International Flavors & Fragrances' food-ingredients division for $4.3 billion including debt, with deal expected to close mid-2026.
- • IFF retains 10% minority stake in the division, positioning shareholders to benefit from potential value appreciation under CVC ownership while maintaining operational cooperation.
- • Food-ingredients unit generated $3.28 billion in revenue last year—IFF's largest division by sales—but faced 2025 year-over-year sales declines and recent asset write-downs despite Q1 2026 revenue recovery.
- • IFF plans to deploy approximately $3.8 billion in net cash proceeds toward debt reduction, targeted share repurchases, and strategic investments, addressing profitability and balance sheet priorities.
- • Transaction reflects IFF's broader portfolio optimization strategy following major acquisitions (including DuPont nutrition business merger in 2021) and recent asset dispositions to improve operational focus and growth trajectory.
Summary
CVC Capital Partners has agreed to acquire the food-ingredients business of International Flavors & Fragrances in a $4.3 billion transaction, marking a significant step in IFF's ongoing portfolio restructuring. The deal, announced Friday, values the division inclusive of assumed debt and is expected to close by mid-2026. IFF will retain a 10% stake in the division following the transaction, a stake designed to ensure continued operational coordination and to provide IFF shareholders with upside exposure should the division's valuation increase under CVC's management.
The food-ingredients business represents IFF's largest revenue-generating division, having generated approximately $3.28 billion in sales in the prior year. However, the unit faced headwinds in 2025, with year-over-year sales declines and a recent asset write-down that raised questions about operational performance. The division has rebounded somewhat, with first-quarter 2026 revenue showing improvement. The business produces a range of products including emulsifiers for food manufacturing efficiency, specialty sweeteners, and gelato paste, serving a diversified global customer base.
The transaction directly supports IFF's strategic objective of improving profitability and financial flexibility. The company expects to realize approximately $3.8 billion in net cash proceeds, which management plans to allocate toward debt reduction, targeted share repurchase programs, and strategic capital investments. This capital deployment signals confidence in IFF's ability to improve shareholder returns while deleveraging its balance sheet following a period of material acquisitions, most notably the 2021 merger with DuPont's nutrition business.
CVC's acquisition provides the private equity firm with established platform exposure in the specialty ingredients sector, including global manufacturing capabilities and proprietary technical assets. The transaction is supported by advisory teams including White & Case and Skadden Arps on the legal side, with financing partners Citi, JPMorgan Chase, and Bank of America supporting the transaction structure. The acquisition reflects broader private equity activity in the specialty chemicals and ingredients space, where established revenue bases, recurring customer relationships, and operational improvement opportunities have attracted significant buyout capital.
The food-ingredients business represents IFF's largest revenue-generating division, having generated approximately $3.28 billion in sales in the prior year. However, the unit faced headwinds in 2025, with year-over-year sales declines and a recent asset write-down that raised questions about operational performance. The division has rebounded somewhat, with first-quarter 2026 revenue showing improvement. The business produces a range of products including emulsifiers for food manufacturing efficiency, specialty sweeteners, and gelato paste, serving a diversified global customer base.
The transaction directly supports IFF's strategic objective of improving profitability and financial flexibility. The company expects to realize approximately $3.8 billion in net cash proceeds, which management plans to allocate toward debt reduction, targeted share repurchase programs, and strategic capital investments. This capital deployment signals confidence in IFF's ability to improve shareholder returns while deleveraging its balance sheet following a period of material acquisitions, most notably the 2021 merger with DuPont's nutrition business.
CVC's acquisition provides the private equity firm with established platform exposure in the specialty ingredients sector, including global manufacturing capabilities and proprietary technical assets. The transaction is supported by advisory teams including White & Case and Skadden Arps on the legal side, with financing partners Citi, JPMorgan Chase, and Bank of America supporting the transaction structure. The acquisition reflects broader private equity activity in the specialty chemicals and ingredients space, where established revenue bases, recurring customer relationships, and operational improvement opportunities have attracted significant buyout capital.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.